US FDA Tweaks Direct Marking Rules In UDI Enforcement Delay
Executive Summary
FDA’s latest update to Unique Device Identification compliance deadlines says the agency won’t enforce direct marking UDI rules for some existing devices if the UDI can be determined in other ways.
You may also be interested in...
FDA Extends Manufacturers’ UDI Compliance Time Due To COVID-19
Due to the ongoing coronavirus crisis, regulators have put pushed back deadlines for meeting UDI requirements. In some instances, they will no longer require direct-mark UDI information if it can be garnered from other data on the device.
US FDA Extends UDI Deadlines For Low-Risk Devices
The agency slowed down its effort to require the overwhelming majority of medical devices to adopt Unique Device Identifiers with a new guidance that would in delay full implementation of the UDI system for lower-risk devices.
Class I Device-Makers Get Wiggle Room As US FDA Pushes UDI Compliance Date To 2020
Manufacturers of low-risk class I products were given an extra two years to comply with FDA's Unique Device Identification requirements to give the agency and industry time to work through challenges posed by incorporating device identifiers into electronic health systems.